Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents

Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who received the injectable intramuscular antiviral medications cabotegravir and rilpivirine for nearly a year after being…

Continue Reading

News Source: medicalxpress.com